Dual HER2-targeted therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual HER2-targeted therapy, covering 2026-01-29 to 2026-01-29. Get the full timeline:
Most recent: Clinical Trial Update: The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted Therapy